Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 131
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period.
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.
The Global Info Research report includes an overview of the development of the Pain Management Drugs industry chain, the market status of Hospitals (Generic Opioids, Branded Opioids), Drugstores (Generic Opioids, Branded Opioids), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pain Management Drugs.
Regionally, the report analyzes the Pain Management Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pain Management Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pain Management Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pain Management Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Generic Opioids, Branded Opioids).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pain Management Drugs market.
Regional Analysis: The report involves examining the Pain Management Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pain Management Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pain Management Drugs:
Company Analysis: Report covers individual Pain Management Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pain Management Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Drugstores).
Technology Analysis: Report covers specific technologies relevant to Pain Management Drugs. It assesses the current state, advancements, and potential future developments in Pain Management Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pain Management Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pain Management Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
Market segment by Application
Hospitals
Drugstores
Others
Market segment by players, this report covers
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pain Management Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pain Management Drugs, with revenue, gross margin and global market share of Pain Management Drugs from 2019 to 2024.
Chapter 3, the Pain Management Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pain Management Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pain Management Drugs.
Chapter 13, to describe Pain Management Drugs research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Pain Management Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pain Management Drugs by Type
1.3.1 Overview: Global Pain Management Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Pain Management Drugs Consumption Value Market Share by Type in 2023
1.3.3 Generic Opioids
1.3.4 Branded Opioids
1.3.5 NSAIDs
1.3.6 Others
1.4 Global Pain Management Drugs Market by Application
1.4.1 Overview: Global Pain Management Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Drugstores
1.4.4 Others
1.5 Global Pain Management Drugs Market Size & Forecast
1.6 Global Pain Management Drugs Market Size and Forecast by Region
1.6.1 Global Pain Management Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Pain Management Drugs Market Size by Region, (2019-2030)
1.6.3 North America Pain Management Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Pain Management Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Pain Management Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Pain Management Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Pain Management Drugs Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Pain Management Drugs Product and Solutions
2.1.4 GSK Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Pain Management Drugs Product and Solutions
2.2.4 Pfizer Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Grunenthal
2.3.1 Grunenthal Details
2.3.2 Grunenthal Major Business
2.3.3 Grunenthal Pain Management Drugs Product and Solutions
2.3.4 Grunenthal Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Grunenthal Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Pain Management Drugs Product and Solutions
2.4.4 Sanofi Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Pain Management Drugs Product and Solutions
2.5.4 Bayer Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bayer Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Pain Management Drugs Product and Solutions
2.6.4 AstraZeneca Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Pain Management Drugs Product and Solutions
2.7.4 Eli Lilly Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Eli Lilly Recent Developments and Future Plans
2.8 Endo
2.8.1 Endo Details
2.8.2 Endo Major Business
2.8.3 Endo Pain Management Drugs Product and Solutions
2.8.4 Endo Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Endo Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Pain Management Drugs Product and Solutions
2.9.4 Merck Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Merck Recent Developments and Future Plans
2.10 Yunnan Baiyao
2.10.1 Yunnan Baiyao Details
2.10.2 Yunnan Baiyao Major Business
2.10.3 Yunnan Baiyao Pain Management Drugs Product and Solutions
2.10.4 Yunnan Baiyao Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Yunnan Baiyao Recent Developments and Future Plans
2.11 Teikoku Seiyaku
2.11.1 Teikoku Seiyaku Details
2.11.2 Teikoku Seiyaku Major Business
2.11.3 Teikoku Seiyaku Pain Management Drugs Product and Solutions
2.11.4 Teikoku Seiyaku Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Teikoku Seiyaku Recent Developments and Future Plans
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Pain Management Drugs Product and Solutions
2.12.4 Teva Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Teva Recent Developments and Future Plans
2.13 J&J
2.13.1 J&J Details
2.13.2 J&J Major Business
2.13.3 J&J Pain Management Drugs Product and Solutions
2.13.4 J&J Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 J&J Recent Developments and Future Plans
2.14 Assertio Therapeutics
2.14.1 Assertio Therapeutics Details
2.14.2 Assertio Therapeutics Major Business
2.14.3 Assertio Therapeutics Pain Management Drugs Product and Solutions
2.14.4 Assertio Therapeutics Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Assertio Therapeutics Recent Developments and Future Plans
2.15 Allergan
2.15.1 Allergan Details
2.15.2 Allergan Major Business
2.15.3 Allergan Pain Management Drugs Product and Solutions
2.15.4 Allergan Pain Management Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Allergan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pain Management Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Pain Management Drugs by Company Revenue
3.2.2 Top 3 Pain Management Drugs Players Market Share in 2023
3.2.3 Top 6 Pain Management Drugs Players Market Share in 2023
3.3 Pain Management Drugs Market: Overall Company Footprint Analysis
3.3.1 Pain Management Drugs Market: Region Footprint
3.3.2 Pain Management Drugs Market: Company Product Type Footprint
3.3.3 Pain Management Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Pain Management Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Pain Management Drugs Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Pain Management Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Pain Management Drugs Market Forecast by Application (2025-2030)
6 North America
6.1 North America Pain Management Drugs Consumption Value by Type (2019-2030)
6.2 North America Pain Management Drugs Consumption Value by Application (2019-2030)
6.3 North America Pain Management Drugs Market Size by Country
6.3.1 North America Pain Management Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Pain Management Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Pain Management Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Pain Management Drugs Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Pain Management Drugs Consumption Value by Type (2019-2030)
7.2 Europe Pain Management Drugs Consumption Value by Application (2019-2030)
7.3 Europe Pain Management Drugs Market Size by Country
7.3.1 Europe Pain Management Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Pain Management Drugs Market Size and Forecast (2019-2030)
7.3.3 France Pain Management Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Pain Management Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Pain Management Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Pain Management Drugs Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Pain Management Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Pain Management Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Pain Management Drugs Market Size by Region
8.3.1 Asia-Pacific Pain Management Drugs Consumption Value by Region (2019-2030)
8.3.2 China Pain Management Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Pain Management Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Pain Management Drugs Market Size and Forecast (2019-2030)
8.3.5 India Pain Management Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Pain Management Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Pain Management Drugs Market Size and Forecast (2019-2030)
9 South America
9.1 South America Pain Management Drugs Consumption Value by Type (2019-2030)
9.2 South America Pain Management Drugs Consumption Value by Application (2019-2030)
9.3 South America Pain Management Drugs Market Size by Country
9.3.1 South America Pain Management Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Pain Management Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Pain Management Drugs Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Pain Management Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Pain Management Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Pain Management Drugs Market Size by Country
10.3.1 Middle East & Africa Pain Management Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Pain Management Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Pain Management Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Pain Management Drugs Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Pain Management Drugs Market Drivers
11.2 Pain Management Drugs Market Restraints
11.3 Pain Management Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Pain Management Drugs Industry Chain
12.2 Pain Management Drugs Upstream Analysis
12.3 Pain Management Drugs Midstream Analysis
12.4 Pain Management Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Pain Management Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pain Management Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Pain Management Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Pain Management Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. GSK Company Information, Head Office, and Major Competitors
Table 6. GSK Major Business
Table 7. GSK Pain Management Drugs Product and Solutions
Table 8. GSK Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. GSK Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Pain Management Drugs Product and Solutions
Table 13. Pfizer Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. Grunenthal Company Information, Head Office, and Major Competitors
Table 16. Grunenthal Major Business
Table 17. Grunenthal Pain Management Drugs Product and Solutions
Table 18. Grunenthal Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Grunenthal Recent Developments and Future Plans
Table 20. Sanofi Company Information, Head Office, and Major Competitors
Table 21. Sanofi Major Business
Table 22. Sanofi Pain Management Drugs Product and Solutions
Table 23. Sanofi Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Sanofi Recent Developments and Future Plans
Table 25. Bayer Company Information, Head Office, and Major Competitors
Table 26. Bayer Major Business
Table 27. Bayer Pain Management Drugs Product and Solutions
Table 28. Bayer Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bayer Recent Developments and Future Plans
Table 30. AstraZeneca Company Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca Pain Management Drugs Product and Solutions
Table 33. AstraZeneca Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. AstraZeneca Recent Developments and Future Plans
Table 35. Eli Lilly Company Information, Head Office, and Major Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Pain Management Drugs Product and Solutions
Table 38. Eli Lilly Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Eli Lilly Recent Developments and Future Plans
Table 40. Endo Company Information, Head Office, and Major Competitors
Table 41. Endo Major Business
Table 42. Endo Pain Management Drugs Product and Solutions
Table 43. Endo Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Endo Recent Developments and Future Plans
Table 45. Merck Company Information, Head Office, and Major Competitors
Table 46. Merck Major Business
Table 47. Merck Pain Management Drugs Product and Solutions
Table 48. Merck Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Merck Recent Developments and Future Plans
Table 50. Yunnan Baiyao Company Information, Head Office, and Major Competitors
Table 51. Yunnan Baiyao Major Business
Table 52. Yunnan Baiyao Pain Management Drugs Product and Solutions
Table 53. Yunnan Baiyao Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Yunnan Baiyao Recent Developments and Future Plans
Table 55. Teikoku Seiyaku Company Information, Head Office, and Major Competitors
Table 56. Teikoku Seiyaku Major Business
Table 57. Teikoku Seiyaku Pain Management Drugs Product and Solutions
Table 58. Teikoku Seiyaku Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Teikoku Seiyaku Recent Developments and Future Plans
Table 60. Teva Company Information, Head Office, and Major Competitors
Table 61. Teva Major Business
Table 62. Teva Pain Management Drugs Product and Solutions
Table 63. Teva Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Teva Recent Developments and Future Plans
Table 65. J&J Company Information, Head Office, and Major Competitors
Table 66. J&J Major Business
Table 67. J&J Pain Management Drugs Product and Solutions
Table 68. J&J Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. J&J Recent Developments and Future Plans
Table 70. Assertio Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Assertio Therapeutics Major Business
Table 72. Assertio Therapeutics Pain Management Drugs Product and Solutions
Table 73. Assertio Therapeutics Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Assertio Therapeutics Recent Developments and Future Plans
Table 75. Allergan Company Information, Head Office, and Major Competitors
Table 76. Allergan Major Business
Table 77. Allergan Pain Management Drugs Product and Solutions
Table 78. Allergan Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Allergan Recent Developments and Future Plans
Table 80. Global Pain Management Drugs Revenue (USD Million) by Players (2019-2024)
Table 81. Global Pain Management Drugs Revenue Share by Players (2019-2024)
Table 82. Breakdown of Pain Management Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Pain Management Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Pain Management Drugs Players
Table 85. Pain Management Drugs Market: Company Product Type Footprint
Table 86. Pain Management Drugs Market: Company Product Application Footprint
Table 87. Pain Management Drugs New Market Entrants and Barriers to Market Entry
Table 88. Pain Management Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Pain Management Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Pain Management Drugs Consumption Value Share by Type (2019-2024)
Table 91. Global Pain Management Drugs Consumption Value Forecast by Type (2025-2030)
Table 92. Global Pain Management Drugs Consumption Value by Application (2019-2024)
Table 93. Global Pain Management Drugs Consumption Value Forecast by Application (2025-2030)
Table 94. North America Pain Management Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Pain Management Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Pain Management Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Pain Management Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Pain Management Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Pain Management Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Pain Management Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Pain Management Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Pain Management Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Pain Management Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Pain Management Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Pain Management Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Pain Management Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Pain Management Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Pain Management Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Pain Management Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Pain Management Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Pain Management Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Pain Management Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Pain Management Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Pain Management Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Pain Management Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Pain Management Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Pain Management Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Pain Management Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Pain Management Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Pain Management Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Pain Management Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Pain Management Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Pain Management Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Pain Management Drugs Raw Material
Table 125. Key Suppliers of Pain Management Drugs Raw Materials
List of Figures
Figure 1. Pain Management Drugs Picture
Figure 2. Global Pain Management Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pain Management Drugs Consumption Value Market Share by Type in 2023
Figure 4. Generic Opioids
Figure 5. Branded Opioids
Figure 6. NSAIDs
Figure 7. Others
Figure 8. Global Pain Management Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Pain Management Drugs Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Drugstores Picture
Figure 12. Others Picture
Figure 13. Global Pain Management Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Pain Management Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Pain Management Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Pain Management Drugs Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Pain Management Drugs Consumption Value Market Share by Region in 2023
Figure 18. North America Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Pain Management Drugs Revenue Share by Players in 2023
Figure 24. Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Pain Management Drugs Market Share in 2023
Figure 26. Global Top 6 Players Pain Management Drugs Market Share in 2023
Figure 27. Global Pain Management Drugs Consumption Value Share by Type (2019-2024)
Figure 28. Global Pain Management Drugs Market Share Forecast by Type (2025-2030)
Figure 29. Global Pain Management Drugs Consumption Value Share by Application (2019-2024)
Figure 30. Global Pain Management Drugs Market Share Forecast by Application (2025-2030)
Figure 31. North America Pain Management Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Pain Management Drugs Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Pain Management Drugs Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Pain Management Drugs Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Pain Management Drugs Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Pain Management Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. France Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Pain Management Drugs Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Pain Management Drugs Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Pain Management Drugs Consumption Value Market Share by Region (2019-2030)
Figure 48. China Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. India Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Pain Management Drugs Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Pain Management Drugs Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Pain Management Drugs Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Pain Management Drugs Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Pain Management Drugs Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Pain Management Drugs Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Pain Management Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. Pain Management Drugs Market Drivers
Figure 66. Pain Management Drugs Market Restraints
Figure 67. Pain Management Drugs Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Pain Management Drugs in 2023
Figure 70. Manufacturing Process Analysis of Pain Management Drugs
Figure 71. Pain Management Drugs Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
GSK Pfizer Grunenthal Sanofi Bayer AstraZeneca Eli Lilly Endo Merck Yunnan Baiyao Teikoku Seiyaku Teva J&J Assertio Therapeutics Allergan
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>